Helix BioPharma Corp. HBP.TO Stock
Helix BioPharma Corp. Price Chart
Helix BioPharma Corp. HBP.TO Financial and Trading Overview
| Helix BioPharma Corp. stock price | 0.19 CAD |
| Previous Close | 0.2 CAD |
| Open | 0.21 CAD |
| Bid | 0.21 CAD x 0 |
| Ask | 0.23 CAD x 0 |
| Day's Range | 0.2 - 0.21 CAD |
| 52 Week Range | 0.16 - 0.3 CAD |
| Volume | 200 CAD |
| Avg. Volume | 2.7K CAD |
| Market Cap | 40M CAD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.5 CAD |
HBP.TO Valuation Measures
| Enterprise Value | 38.67M CAD |
| Trailing P/E | N/A |
| Forward P/E | -1.8181819 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 40 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -7.312 |
Trading Information
Helix BioPharma Corp. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -4.76% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.3 CAD |
| 52 Week Low | 0.16 CAD |
| 50-Day Moving Average | 0.21 CAD |
| 200-Day Moving Average | 0.21 CAD |
HBP.TO Share Statistics
| Avg. Volume (3 month) | 2.7K CAD |
| Avg. Daily Volume (10-Days) | 1.45K CAD |
| Shares Outstanding | 200.02M |
| Float | 163.3M |
| Short Ratio | 0.05 |
| % Held by Insiders | 18.35% |
| % Held by Institutions | 13.17% |
| Shares Short | 236 |
| Short % of Float | 0% |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2022 |
| Most Recent Quarter (mrq) | April 30, 2023 |
| Next Fiscal Year End | July 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -168.99% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -5289000 CAD |
| Net Income Avi to Common (ttm) | -5522000 CAD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.33M CAD |
| Total Cash Per Share (mrq) | 0.007 CAD |
| Total Debt (mrq) | 0 CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.301 |
| Book Value Per Share (mrq) | 0.005 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5806000 CAD |
| Levered Free Cash Flow (ttm) | -3404750 CAD |
Profile of Helix BioPharma Corp.
| Country | Canada |
| State | ON |
| City | Toronto |
| Address | 401 Bay Street |
| ZIP | M5H 2Y4 |
| Phone | N/A |
| Website | https://www.helixbiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Helix BioPharma Corp. operates as an immune-oncology company in Canada. The company is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.
Q&A For Helix BioPharma Corp. Stock
What is a current HBP.TO stock price?
Helix BioPharma Corp. HBP.TO stock price today per share is 0.19 CAD.
How to purchase Helix BioPharma Corp. stock?
You can buy HBP.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Helix BioPharma Corp.?
The stock symbol or ticker of Helix BioPharma Corp. is HBP.TO.
Which industry does the Helix BioPharma Corp. company belong to?
The Helix BioPharma Corp. industry is Biotechnology.
How many shares does Helix BioPharma Corp. have in circulation?
The max supply of Helix BioPharma Corp. shares is 229.44M.
What is Helix BioPharma Corp. Price to Earnings Ratio (PE Ratio)?
Helix BioPharma Corp. PE Ratio is now.
What was Helix BioPharma Corp. earnings per share over the trailing 12 months (TTM)?
Helix BioPharma Corp. EPS is -0.03 CAD over the trailing 12 months.
Which sector does the Helix BioPharma Corp. company belong to?
The Helix BioPharma Corp. sector is Healthcare.